From: Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
Parameter
Data
Gender
Male
10 (40%)
Female
15 (60%)
Age (years)
Median
54
Range
15–78
Sokal score at diagnosis
Low
Intermediate
High
5 (20%)